US politics
fromIPWatchdog.com | Patents & Intellectual Property Law
23 hours agoChamber Urges Trump to Refocus Drug Pricing Efforts
MFN drug-pricing risks undermining U.S. biopharma innovation, potentially causing millions of job losses, sharply reduced clinical trials, and weakened R&D incentives.